Literature DB >> 2786805

Vitamin D status and concentrations of serum vitamin D metabolites and osteocalcin in elderly patients with femoral neck fracture: a follow-up study.

C Lamberg-Allardt1, J von Knorring, P Slätis, T Holmström.   

Abstract

Vitamin D status and the serum osteocalcin concentration in patients with femoral neck fractures were studied as follows. Thirty-seven elderly patients (P) with fracture of the femoral neck were studied, whereas 24 age-matched persons (C) seen at the out-patient department for non-orthopaedic reasons served as controls. The dietary intake of vitamin D, estimated using a vitamin D score based on food items known to be the main sources of vitamin D, was significantly lower in the patients than in the controls. There was no difference in the serum 25-hydroxy-vitamin D (25-OH-D) (P: 22.3 +/- 7.5 nmol/l; C: 27.5 +/- 13.5) or the serum 1,25-dihydroxy-vitamin D3 concentration (P: 86 +/- 43 pmol/l; 31) C: 85 +/- 31) between the groups. The 25-OH-D concentration was, however, low as compared to reference values, suggesting vitamin D deficiency in both groups. There was no difference in the serum osteocalcin concentration between the groups (P: 3.1 +/- 1.7 micrograms/l; C: 3.4 +/- 1.5). One year later the serum osteocalcin concentrations (5.9 +/- 2.2 micrograms/l, n = 11) was significantly higher (P less than 0.005) in the patients than at the time of the fracture (3.2 +/- 2.2 micrograms/l), indicating an active bone turnover in the patients still present 1 year after the fracture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786805

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  8 in total

1.  Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland.

Authors:  Ilona Nurmi; Juha-Pekka Kaukonen; Peter Lüthje; Helena Naboulsi; Salla Tanninen; Matti Kataja; Maija-Leena Kallio; Marjatta Leppilampi
Journal:  Osteoporos Int       Date:  2005-08-24       Impact factor: 4.507

2.  The hormonal profile of hip fracture female patients differs from community-dwelling peers over a 1-year follow-up period.

Authors:  A R Cappola; W G Hawkes; N Blocher; J Yu-Yahiro; D Orwig; L Fredman; R R Miller; J M Guralnik; J Magaziner
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

3.  Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency.

Authors:  O Sahota; M K Mundey; P San; I M Godber; D J Hosking
Journal:  Osteoporos Int       Date:  2006-04-05       Impact factor: 4.507

4.  Efficacy of optimization of vitamin D in preventing osteoporosis and osteoporotic fractures: A systematic review.

Authors:  Kazutoshi Nakamura; Masayuki Iki
Journal:  Environ Health Prev Med       Date:  2006-07       Impact factor: 3.674

5.  Impairment of bone turnover in elderly women with hip fracture.

Authors:  K Akesson; P Vergnaud; E Gineyts; P D Delmas; K J Obrant
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

6.  Changes in the serum level of vitamin d during healing of tibial and femoral shaft fractures.

Authors:  Hossein Ettehad; Ahmadreza Mirbolook; Fereshteh Mohammadi; Mohammadsadegh Mousavi; Hannan Ebrahimi; Ardeshir Shirangi
Journal:  Trauma Mon       Date:  2014-01-25

7.  Fixation using alternative implants for the treatment of hip fractures (FAITH-2): design and rationale for a pilot multi-centre 2 × 2 factorial randomized controlled trial in young femoral neck fracture patients.

Authors:  Gerard P Slobogean; Sheila Sprague; Sofia Bzovsky; Diane Heels-Ansdell; Lehana Thabane; Taryn Scott; Mohit Bhandari
Journal:  Pilot Feasibility Stud       Date:  2019-05-28

8.  Quantitative heel ultrasonography, 25-hydroxyvitamin D, and urine amino-terminal cross-linking telopeptide of type I collagen in patients with a recent hip fracture.

Authors:  Edward Colt; George Gorich; Stephen Quinnan; Ramona Raj; John Thornton; Brenda Matti; Richard Pierson; Eileen Quinlan
Journal:  J Ultrasound Med       Date:  2009-03       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.